FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2775841454> ?p ?o ?g. }

• W2775841454 endingPage "1520" @default.
• W2775841454 startingPage "1512" @default.
• W2775841454 abstract "Frailty is associated with adverse events, length of stay, and nonhome discharge after vascular surgery. Frailty measures based on walking-based tests may be impractical or invalid for patients with walking impairment from symptoms or sequelae of vascular disease. We hypothesized that grip strength is associated with frailty, comorbidity, and cardiac risk among patients with vascular disease.Dominant hand grip strength was measured during ambulatory clinic visits among patients with vascular disease (abdominal aortic aneurysm [AAA], carotid stenosis, and peripheral artery disease [PAD]). Frailty prevalence was defined on the basis of the 20th percentile of community-dwelling population estimates adjusted for age, gender, and body mass index. Associations between grip strength, Charlson Comorbidity Index (CCI), Revised Cardiac Risk Index (RCRI), and sarcopenia (based on total psoas area for patients with cross-sectional abdominal imaging) were evaluated using linear and logistic regression.Grip strength was measured in 311 participants; all had sufficient data for CCI calculation, 217 (69.8%) had sufficient data for RCRI, and 88 (28.3%) had cross-sectional imaging permitting psoas measurement. Eighty-six participants (27.7%) were categorized as frail on the basis of grip strength. Frailty was associated with CCI (odds ratio, 1.86; 95% confidence interval, 1.34-2.57; P = .0002) in the multivariable model. Frail participants also had a higher average number of RCRI components vs nonfrail patients (mean ± standard deviation, 1.8 ± 0.8 for frail vs 1.5 ± 0.7 for nonfrail; P = .018); frailty was also associated with RCRI in the adjusted multivariable model (odds ratio, 1.75; 95% confidence interval, 1.16-2.64; P = .008). Total psoas area was lower among patients categorized as frail vs nonfrail on the basis of grip strength (21.0 ± 6.6 vs 25.4 ± 7.4; P = .010). Each 10 cm2 increase in psoas area was associated with a 5.7 kg increase in grip strength in a multivariable model adjusting for age and gender (P < .0001). Adjusted least squares mean psoas diameter estimates were 25.5 ± 1.1 cm2 for participants with AAA, 26.7 ± 2.0 cm2 for participants with carotid stenosis, and 22.7 ± 0.8 cm2 for participants with PAD (P = .053 for PAD vs AAA; P = .057 for PAD vs carotid stenosis; and P = .564 for AAA vs carotid stenosis).Grip strength is useful for identifying frailty among patients with vascular disease. Frail status based on grip strength is associated with comorbidity, cardiac risk, and sarcopenia in this population. These findings suggest that grip strength may have utility as a simple and inexpensive risk screening tool that is easily implemented in ambulatory clinics, avoids the need for imaging, and overcomes possible limitations of walking-based measures. Lower mean psoas diameters among patients with PAD vs other diagnoses may warrant consideration of specific approaches to morphomic analysis." @default.
• W2775841454 created "2018-01-05" @default.
• W2775841454 creator A5008129967 @default.
• W2775841454 creator A5019350828 @default.
• W2775841454 creator A5021188066 @default.
• W2775841454 creator A5054149098 @default.
• W2775841454 creator A5056655399 @default.
• W2775841454 creator A5073038612 @default.
• W2775841454 creator A5076069499 @default.
• W2775841454 creator A5085936810 @default.
• W2775841454 creator A5090340177 @default.
• W2775841454 date "2018-05-01" @default.
• W2775841454 modified "2023-10-13" @default.
• W2775841454 title "Grip strength measurement for frailty assessment in patients with vascular disease and associations with comorbidity, cardiac risk, and sarcopenia" @default.
• W2775841454 cites W1524807258 @default.
• W2775841454 cites W1576645826 @default.
• W2775841454 cites W1794019140 @default.
• W2775841454 cites W1974704788 @default.
• W2775841454 cites W1975412844 @default.
• W2775841454 cites W1977743540 @default.
• W2775841454 cites W2000445173 @default.
• W2775841454 cites W2006990255 @default.
• W2775841454 cites W2030061020 @default.
• W2775841454 cites W2045810535 @default.
• W2775841454 cites W2051376253 @default.
• W2775841454 cites W2063448619 @default.
• W2775841454 cites W2080921526 @default.
• W2775841454 cites W2087000019 @default.
• W2775841454 cites W2093274439 @default.
• W2775841454 cites W2098136024 @default.
• W2775841454 cites W2104655786 @default.
• W2775841454 cites W2104750100 @default.
• W2775841454 cites W2107640783 @default.
• W2775841454 cites W2109982307 @default.
• W2775841454 cites W2110843198 @default.
• W2775841454 cites W2116041825 @default.
• W2775841454 cites W2121566433 @default.
• W2775841454 cites W2121866629 @default.
• W2775841454 cites W2154467062 @default.
• W2775841454 cites W2155858865 @default.
• W2775841454 cites W2164059021 @default.
• W2775841454 cites W2164186760 @default.
• W2775841454 cites W2169499314 @default.
• W2775841454 cites W2190676960 @default.
• W2775841454 cites W2202559190 @default.
• W2775841454 cites W2281667236 @default.
• W2775841454 doi "https://doi.org/10.1016/j.jvs.2017.08.078" @default.
• W2775841454 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29276105" @default.
• W2775841454 hasPublicationYear "2018" @default.
• W2775841454 type Work @default.
• W2775841454 sameAs 2775841454 @default.
• W2775841454 citedByCount "67" @default.
• W2775841454 countsByYear W27758414542018 @default.
• W2775841454 countsByYear W27758414542019 @default.
• W2775841454 countsByYear W27758414542020 @default.
• W2775841454 countsByYear W27758414542021 @default.
• W2775841454 countsByYear W27758414542022 @default.
• W2775841454 countsByYear W27758414542023 @default.
• W2775841454 crossrefType "journal-article" @default.
• W2775841454 hasAuthorship W2775841454A5008129967 @default.
• W2775841454 hasAuthorship W2775841454A5019350828 @default.
• W2775841454 hasAuthorship W2775841454A5021188066 @default.
• W2775841454 hasAuthorship W2775841454A5054149098 @default.
• W2775841454 hasAuthorship W2775841454A5056655399 @default.
• W2775841454 hasAuthorship W2775841454A5073038612 @default.
• W2775841454 hasAuthorship W2775841454A5076069499 @default.
• W2775841454 hasAuthorship W2775841454A5085936810 @default.
• W2775841454 hasAuthorship W2775841454A5090340177 @default.
• W2775841454 hasBestOaLocation W27758414541 @default.
• W2775841454 hasConcept C126322002 @default.
• W2775841454 hasConcept C141071460 @default.
• W2775841454 hasConcept C151956035 @default.
• W2775841454 hasConcept C156957248 @default.
• W2775841454 hasConcept C164705383 @default.
• W2775841454 hasConcept C1862650 @default.
• W2775841454 hasConcept C2776098176 @default.
• W2775841454 hasConcept C2776214593 @default.
• W2775841454 hasConcept C2777433710 @default.
• W2775841454 hasConcept C2779159551 @default.
• W2775841454 hasConcept C2779993416 @default.
• W2775841454 hasConcept C2908647359 @default.
• W2775841454 hasConcept C44249647 @default.
• W2775841454 hasConcept C71924100 @default.
• W2775841454 hasConcept C99454951 @default.
• W2775841454 hasConceptScore W2775841454C126322002 @default.
• W2775841454 hasConceptScore W2775841454C141071460 @default.
• W2775841454 hasConceptScore W2775841454C151956035 @default.
• W2775841454 hasConceptScore W2775841454C156957248 @default.
• W2775841454 hasConceptScore W2775841454C164705383 @default.
• W2775841454 hasConceptScore W2775841454C1862650 @default.
• W2775841454 hasConceptScore W2775841454C2776098176 @default.
• W2775841454 hasConceptScore W2775841454C2776214593 @default.
• W2775841454 hasConceptScore W2775841454C2777433710 @default.
• W2775841454 hasConceptScore W2775841454C2779159551 @default.
• W2775841454 hasConceptScore W2775841454C2779993416 @default.
• W2775841454 hasConceptScore W2775841454C2908647359 @default.
• W2775841454 hasConceptScore W2775841454C44249647 @default.
• W2775841454 hasConceptScore W2775841454C71924100 @default.

• next